1. Home
  2. TNGX vs AGNCM Comparison

TNGX vs AGNCM Comparison

Compare TNGX & AGNCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • AGNCM
  • Stock Information
  • Founded
  • TNGX 2014
  • AGNCM N/A
  • Country
  • TNGX United States
  • AGNCM United States
  • Employees
  • TNGX N/A
  • AGNCM 53
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • AGNCM Real Estate Investment Trusts
  • Sector
  • TNGX Health Care
  • AGNCM Real Estate
  • Exchange
  • TNGX Nasdaq
  • AGNCM Nasdaq
  • Market Cap
  • TNGX 990.5M
  • AGNCM N/A
  • IPO Year
  • TNGX N/A
  • AGNCM N/A
  • Fundamental
  • Price
  • TNGX $9.89
  • AGNCM $25.16
  • Analyst Decision
  • TNGX Strong Buy
  • AGNCM
  • Analyst Count
  • TNGX 8
  • AGNCM 0
  • Target Price
  • TNGX $14.86
  • AGNCM N/A
  • AVG Volume (30 Days)
  • TNGX 822.0K
  • AGNCM N/A
  • Earning Date
  • TNGX 08-05-2024
  • AGNCM N/A
  • Dividend Yield
  • TNGX N/A
  • AGNCM N/A
  • EPS Growth
  • TNGX N/A
  • AGNCM N/A
  • EPS
  • TNGX N/A
  • AGNCM N/A
  • Revenue
  • TNGX $37,232,000.00
  • AGNCM N/A
  • Revenue This Year
  • TNGX N/A
  • AGNCM N/A
  • Revenue Next Year
  • TNGX $2.40
  • AGNCM N/A
  • P/E Ratio
  • TNGX N/A
  • AGNCM N/A
  • Revenue Growth
  • TNGX 49.72
  • AGNCM N/A
  • 52 Week Low
  • TNGX $2.88
  • AGNCM N/A
  • 52 Week High
  • TNGX $13.03
  • AGNCM N/A
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 59.16
  • AGNCM 50.65
  • Support Level
  • TNGX $9.26
  • AGNCM $24.90
  • Resistance Level
  • TNGX $9.96
  • AGNCM $25.33
  • Average True Range (ATR)
  • TNGX 0.66
  • AGNCM 0.11
  • MACD
  • TNGX -0.00
  • AGNCM -0.00
  • Stochastic Oscillator
  • TNGX 88.99
  • AGNCM 55.21

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About AGNCM AGNC Investment Corp. Depositary Shares rep 6.875% Series D Fixed-to-Floating Cumulative Redeemable Preferred Stock

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage or real estate markets.

Share on Social Networks: